Ketoacidosis
04-26-2022 | Ketoacidosis | News
Subcutaneous insulin protocol feasible for DKA
Implementing a subcutaneous insulin protocol for the treatment of diabetic ketoacidosis significantly reduces intensive care admissions and readmission to hospital within 30 days of discharge without increasing hypoglycemia, research shows.
09-28-2021 | EASD 2021 | Conference coverage | News
DKA presentation similar for type 1 and type 2 diabetes
Diabetic ketoacidosis is three times more common with type 1 diabetes than with type 2 diabetes, but episode presentation and severity are similar between the two groups, show data presented at the virtual 57th EASD Annual Meeting.